Last reviewed · How we verify
NCT00165724
Alzheimer's Disease Long-term Follow-up Study (ALF Study)
Phase 4 trial testing Donepezil Hydrochloride in Alzheimer's Disease in 114 participants. Completed in 31 December 2006.
31 July 2006
Quick facts
| Lead sponsor | Eisai Korea Inc. |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 114 |
| Start date | 30 June 2004 |
| Primary completion | 31 July 2006 |
| Estimated completion | 31 December 2006 |
| Sites | 7 locations across South Korea |
Drugs / interventions tested
- Donepezil Hydrochloride — full drug profile →
Conditions studied
- Alzheimer's Disease — all drugs for Alzheimer's Disease →
Sponsor
Eisai Korea Inc. — full company profile →
Who can join
Adults 40 to 90, any sex, with Alzheimer's Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Open study for efficacy and safety of donepezil treatment during 48 weeks
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00165724
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Donepezil Hydrochloride
Trials testing the same drug.
- NCT06828289 — Rivastigmine Mini-Tablet for Alzheimer's Disease · not yet recruiting
- NCT05709301 — Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease · Phase 2 · unknown
- NCT05078944 — Progress of Mild Alzheimer's Disease in Participants on Acupuncture Versus Sham Acupuncture · NA · completed
- NCT04013477 — Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults · Phase 1 · completed
- NCT03907371 — The Effect of Donepezil in Radiotherapy-related Cognitive Impairment. · Phase 2 · unknown
Other recruiting trials for Alzheimer's Disease
Currently open trials in the same condition.
- NCT07457138 — Lombard Cohort of Brain Health Services · recruiting
- NCT07234942 — A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants Wit · Phase 1 · recruiting
- NCT07479914 — Art of Memory for Cognitive Enhancement in the Monza Brain Health Service · NA · active not recruiting
- NCT07214727 — A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease · Phase 1 · recruiting
- NCT07105709 — Open-label Extension Study in Participants With Early Alzheimer's Disease · Phase 2 · recruiting
Other Eisai Korea Inc. trials
Trials by the same sponsor.
- NCT06964113 — A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine · Phase 4 · recruiting
- NCT06810960 — A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease · recruiting
- NCT06625242 — A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis · Phase 4 · active not recruiting
- NCT06246123 — A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants · recruiting
- NCT05533814 — A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizure · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00165724 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eisai Korea Inc.
- Last refreshed: 30 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00165724.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing